Advancing an Oral Alternative to Infused and Injected Therapies for HAE

Wim Souverijns, chief community engagement and commercial officer for Pharvaris, discusses hereditary angioedema, Pharvaris’ efforts to develop a convenient oral alternative to existing therapies, and why it believes it will be able to provide an effective alternative that is safe, tolerable, and convenient.